1.Changes of Specific Immunogloblins Against Dihperia Toxoid After DPT Vaccination.
Byung Sook PARK ; Byung An SHIM ; Kyung Jin SHIN ; Soo Chul CHOI ; Juung Soo KIM
Journal of the Korean Pediatric Society 1988;31(9):1126-1132
No abstract available.
Vaccination*
2.A study on the presence of anti-HBs at 4 years after hepatitis-B vaccination.
You Lan PYEON ; Wan Shin KIM ; Jung Jin CHO
Journal of the Korean Academy of Family Medicine 1992;13(1):35-41
No abstract available.
Vaccination*
3.Principles of Vaccination.
Journal of the Korean Medical Association 1997;40(12):1589-1595
No abstract available.
Vaccination*
4.Liability in Side-effects of Vaccination.
Journal of the Korean Pediatric Society 1986;29(6):110-111
No abstract available.
Vaccination*
5.Prevalence and Risk Factors of Hepatitis B in First-time Blood Donors at National Blood Centre after Implementation of National Vaccination Programme
Malaysian Journal of Medicine and Health Sciences 2018;14(Supplement 1):11-16
Introduction: Hepatitis B virus (HBV) infection is one of the major public health problems in Malaysia. It remains the most common permanent deferral among blood donors. In Malaysia, the national vaccination programme has been introduced since 1989 to prevent HBV transmission. The objective of this study is to determine the prevalence and associated risk factors of HBV infection among first-time blood donors after the implementation of the national hepatitis B vaccination programme. Methods: This is a retrospective cohort study involving tracing of the database of National Blood Centre Malaysia. The record of first-time blood donors who had donated between 1st January 2010 and 31st December 2015 and were screened HBV positive was reviewed and analysed. Results: There were 376,737 first-time donors who had donated blood and 575 of them screened positive for HBV. The overall prevalence of seropositive for hepatitis B was 0.15%. The prevalence was higher at 0.23% among donors born before the year 1989 (pre-vaccination era) compared to 0.05% among donors born in and after the year 1989 (post-vaccination era). Perinatal transmission was found to have 15 times higher odds of developing HBV infection as compared to those who had the combination of risk factors among those born after the year 1989 (adjusted OR=14.95, 95% CI 1.80=124.01). Conclusion: The implementation of the national vaccination programme reduced the prevalence of hepatitis B among donors who received vaccination at birth compared to those who did not.
Vaccination
6.Knowledge, attitude and compliance of employees in a tertiary hospital in Iloilo City with the 2012 Recommended Immunization for Filipino Healthcare Workers
The Filipino Family Physician 2017;55(4):173-182
Background:
To determine the level of knowledge, attitude and compliance of employees in St. Paul’s Hospital in Iloilo
City to the 2012 Recommended Immunization for Filipino Healthcare Workers
Methodology:
This was a cross-sectional study participated in by 261 employees. An expert-validated research instrument
was used during the survey with simple random sampling as a method in selecting study participants. Socio-demographic
profile, health status, awareness of the 2012 Recommended Immunization for Healthcare Workers, their knowledge,
attitude, and compliance to it, and the reasons why they received or refused vaccination were described. Descriptive
statistics were utilized for data analysis.
Results:
Nine out of ten study participants were either moderately knowledgeable (51.3%) or highly knowledgeable
(35.2%) on the said immunization schedule. As to attitude, seven out of ten study participants (74.7%) have favorable
attitude while the remaining 25% have either ambivalent (24.1%) or unfavorable (1.2%) attitude. With regard to compliance,
nine out of ten study participants either have better (85.82%) or excellent (10.48%) level of compliance and about 4%
(3.7%) have poor level of compliance. The top three reasons for having vaccination are: “It protects my health” (85.4%),
“It is safe” (81.6%), and “It is effective” (76.5%). The study participants’ top three reasons for not receiving vaccination
are: “It is expensive” (78%), “I’m busy” (41.9%), and “I forgot” (32.3%).
Conclusion
Study participants’ level of awareness, knowledge, attitude, and compliance to 2012 Recommended
Immunization for Healthcare Workers were far from the optimum level. Most were aware of the guidelines, moderately
knowledgeable and complied to it in general. Why they either complied or refused to follow the guidelines appeared to
be personal in nature.
Vaccination
7.Hepatitis B examination and recognition change after 1 year in girls' high school students.
Ill Hwan KIM ; Ok Min KIM ; Chul Gab LEE
Journal of the Korean Academy of Family Medicine 2001;22(8):1271-1278
BACKGROUND: Korea Academy of Family Medicine recommands HBsAb and HBsAb test in youth health promotion program. Adequate management are necessary for prevention of vertical transmission at perinatal period, especially girls' high school students as a future's conceivable woman. Health examination program for the first grade students of high school which was established by the Educational Ministry has been acted since 1998. So, through the students health examination we'd like to find an adequate method of prevention and management in hepatitis B. METHODS: Our study examines HBs Ag/Ab about girls' high school students at two high schools in a city. According to the results of hepatitis B, active intervention in carrier group, passive intervention in candidate were done. And then a year later, hepatitis B management was investigated through the questionnaire. RESULTS: In active intervention group, regular check up of hepatitis B is 21.4%, hepatitis B blood test in family is 39.3% and in passive intervention group, hepatitis B vaccination rate after health examiantion is 9.1%. CONCLUSION: More active intervention such as mass vaccination are required in health examination for the purpose of hepatitis B management at youth.
Adolescent
;
Female
;
Health Promotion
;
Hematologic Tests
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Korea
;
Mass Vaccination
;
Vaccination
;
Surveys and Questionnaires
8.Immunogenicity and efficacy of Rabivac vaccine for animal rabies control in Morocco.
Sami DARKAOUI ; Ouafaa FASSI FIHRI ; Jean Luc SCHEREFFER ; Nadia ABOULFIDAA ; Marine WASNIEWSKI ; Karima ZOUINE ; Mohammed BOUSLIKHANE ; Khadija Id Sidi YAHIA ; Florence CLIQUET
Clinical and Experimental Vaccine Research 2016;5(1):60-69
PURPOSE: To fight animal rabies, Moroccan veterinary authorities organize annual dog mass vaccination campaigns using Rabivac vaccine, an inactivated adjuvanted cell culture veterinary rabies vaccine. Two experiments were undertaken to assess the efficacy and immunogenicity of Rabivac. MATERIALS AND METHODS: The first experiment involved 13 caged dogs (8 vaccinated and 5 negative controls). Dogs were bled at day 0 (D0) and at days D7, D14, D21, D28, D35, D49, D56, D64, D70, D77, D84, D91, D98, D105, D112, and D119 post-vaccination. At D121, a virulent challenge was performed. After 70 days monitoring period, seven out of eight vaccinated dogs survived the challenge (one dog succumbed to a mesenteric torsion accident) and four out of five controls succumbed. All vaccinated dogs seroconverted and the control dogs remained negative. The second experiment consisted in a field study involving 919 owned dogs randomly selected in eight Moroccan districts located in different parts of the country. The dogs were identified and vaccinated by the parenteral route and bled on the vaccination day (D0) and on D30. RESULTS: Ninety-two percent of dogs developed a positive rabies virus neutralizing antibody response to vaccination and 24% were positive at D0, suggesting that dogs were previously vaccinated. The increase in rabies antibody titers was highly significant in all districts. No significant difference seemed occurring between the geographical status (rural, semiurban, or urban) of the districts on the results obtained. CONCLUSION: Rabivac is efficacious both in experimental and field conditions. This supports its use in dog mass vaccination campaigns.
Animals*
;
Antibodies, Neutralizing
;
Cell Culture Techniques
;
Dogs
;
Mass Vaccination
;
Morocco*
;
Rabies Vaccines
;
Rabies virus
;
Rabies*
;
Vaccination
9.Mucosal vaccine adjuvants update.
Joon Haeng RHEE ; Shee Eun LEE ; Soo Young KIM
Clinical and Experimental Vaccine Research 2012;1(1):50-63
Mucosal vaccination, capable of inducing protective immune responses both in the mucosal and systemic immune compartments, has many advantages and is regarded as a blue ocean in the vaccine industry. Mucosal vaccines can offer lower costs, better accessability, needle-free delivery, and higher capacity of mass immunizations during pandemics. However, only very limited number of mucosal vaccines was approved for human use in the market yet. Generally, induction of immune responses following mucosal immunization requires the co-administration of appropriate adjuvants that can initiate and support the effective collaboration between innate and adaptive immunity. Classically, adjuvant researches were rather empirical than keenly scientific. However, during last several years, fundamental scientific achievements in innate immunity have been translated into the development of new mucosal adjuvants. This review focuses on recent developments in the concepts of adjuvants and innate immunity, mucosal immunity with special interest of vaccine development, and basic and applied researches in mucosal adjuvant.
Achievement
;
Adaptive Immunity
;
Cooperative Behavior
;
Humans
;
Immunity, Innate
;
Immunity, Mucosal
;
Immunization
;
Mass Vaccination
;
Pandemics
;
Vaccination
;
Vaccines
10.Data Fitting and Scenario Analysis of Vaccination in the 2014 Ebola Outbreak in Liberia
Osong Public Health and Research Perspectives 2019;10(3):187-201
OBJECTIVES: This study aimed to extend an epidemiological model (SEIHFR) to analyze epidemic trends, and evaluate intervention efficacy. METHODS: SEIHFR was modified to examine disease transmission dynamics after vaccination for the Ebola outbreak. Using existing data from Liberia, sensitivity analysis of various epidemic scenarios was used to inform the model structure, estimate the basic reproduction number ℜ₀ and investigate how the vaccination could effectively change the course of the epidemic. RESULTS: If a randomized mass vaccination strategy was adopted, vaccines would be administered prophylactically or as early as possible (depending on the availability of vaccines). An effective vaccination rate threshold for Liberia was estimated as 48.74% among susceptible individuals. If a ring vaccination strategy was adopted to control the spread of the Ebola virus, vaccines would be given to reduce the transmission rate improving the tracing rate of the contact persons of an infected individual. CONCLUSION: The extended SEIHFR model predicted the total number of infected cases, number of deaths, number of recoveries, and duration of outbreaks among others with different levels of interventions such as vaccination rate. This model may be used to better understand the spread of Ebola and develop strategies that may achieve a disease-free state.
Africa, Western
;
Basic Reproduction Number
;
Disease Outbreaks
;
Ebolavirus
;
Humans
;
Liberia
;
Mass Vaccination
;
Vaccination
;
Vaccines